sofosbuvir has been researched along with Bleeding in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhayani, V; Desai, P; Kabrawala, M; Mehta, R; Nandwani, S; Parekh, V; Patel, S | 1 |
| Berg, T; Ende, K; Kullig, U; Schiefke, I; Stein, K; Wiegand, J | 1 |
1 trial(s) available for sofosbuvir and Bleeding
| Article | Year |
|---|---|
Interferon-free treatment of chronic hepatitis C virus infection in patients with inherited bleeding disorders.
Topics: Adult; Antiviral Agents; Blood Coagulation Disorders, Inherited; Female; Hemorrhage; Hepatitis C, Chronic; Humans; Interferons; Liver Cirrhosis; Male; Middle Aged; Sofosbuvir; Treatment Outcome | 2017 |
1 other study(ies) available for sofosbuvir and Bleeding
| Article | Year |
|---|---|
Daclatasvir-Sofosbuvir for treatment of hepatitis C virus in patients with inherited bleeding disorders.
Topics: Adult; Antiviral Agents; Carbamates; Drug Therapy, Combination; Female; Genetic Diseases, Inborn; Hemorrhage; Hepatitis C; Humans; Imidazoles; Male; Middle Aged; Pyrrolidines; Retrospective Studies; Sofosbuvir; Treatment Outcome; Valine | 2017 |